Literature DB >> 11780720

A case of influenza subtype A virus-induced fulminant myocarditis: an experience of percutaneous cardio-pulmonary support (PCPS) treatment and immunohistochemical analysis.

M Miura1, Y Asaumi, Y Wada, K Ogata, T Sato, T Sugawara, M Yano, M Mitsu-Oka, O Takai, K Ota, K Namiki, D Sato, E Sato, H Nagura, T Kimura.   

Abstract

A 64-year-old man was admitted to the emergency center of Furukawa City Hospital because of common cold-like symptoms and hypotension. He was diagnosed as fulminant myocarditis with cardiogenic shock and arrhythmia elicited by influenza virus subtype A. Cardiac angiography, echocardiography and biopsy also showed myocarditis, and serum antibody titer to influenza virus subtype A was increased to 4-fold in paired serums. Treatments of both percutaneous cardio-pulmonary support (PCPS) and intra-aortic balloon pumping (IABP) were carried out to sustain the general circulation. PCPS treatment was discontinued on the 25th day of the admission, but IABP was continued. Finally, he died of multiple organ failure. The autopsy revealed myocardial necrosis with a slight fibrosis and a small amount of lymphocytic infiltration into the ventricular wall, which were compatible with restrictive myocarditis. Moreover, immunohistochemical analysis also showed the presence of viral antigens in cardiac myocytes. This case clearly showed that PCPS and IABP can be beneficial to sustain the general circulation in fulminant myocarditis, but cardiac pumping function failed completely to recover from myocardial damage.

Entities:  

Mesh:

Year:  2001        PMID: 11780720     DOI: 10.1620/tjem.195.11

Source DB:  PubMed          Journal:  Tohoku J Exp Med        ISSN: 0040-8727            Impact factor:   1.848


  8 in total

1.  Fatal influenza A infection with Staphylococcus aureus superinfection in a 49-year-old woman presenting as sudden death.

Authors:  M Tsokos; B Zöllner; H-H Feucht
Journal:  Int J Legal Med       Date:  2004-08-19       Impact factor: 2.686

2.  Successful management of fulminant influenza A subtype H1N1 myocarditis.

Authors:  Miguel Cobas; Lilian Abbo; Miguel Santos; Clara Baccini-Jauregui; Si Pham
Journal:  BMJ Case Rep       Date:  2010-09-17

3.  Influenza-associated cardiac injury: a disease of the cardiac conduction system?

Authors:  Alexandros Protonotarios; Federica Marelli-Berg
Journal:  Cardiovasc Res       Date:  2021-02-22       Impact factor: 10.787

4.  Fulminant myocarditis demonstrating uncommon morphology--a report of two autopsy cases.

Authors:  Kuniyuki Oka; Koji Oohira; Yasushi Yatabe; Toshio Tanaka; Kozo Kurano; Rie Kosugi; Minoru Murata; Hando Hakozaki; Toshio Nishikawa; Yutaka Tsutsumi
Journal:  Virchows Arch       Date:  2005-01-25       Impact factor: 4.064

5.  Development of real time RT-PCR assays for detection of type A influenza virus and for subtyping of avian H5 and H7 hemagglutinin subtypes.

Authors:  Francesca Sidoti; Francesca Rizzo; Cristina Costa; Sara Astegiano; Antonio Curtoni; Maria Lucia Mandola; Rossana Cavallo; Massimiliano Bergallo
Journal:  Mol Biotechnol       Date:  2010-01       Impact factor: 2.695

Review 6.  The hidden burden of influenza: A review of the extra-pulmonary complications of influenza infection.

Authors:  Subhashini A Sellers; Robert S Hagan; Frederick G Hayden; William A Fischer
Journal:  Influenza Other Respir Viruses       Date:  2017-09       Impact factor: 4.380

7.  Human influenza A virus causes myocardial and cardiac-specific conduction system infections associated with early inflammation and premature death.

Authors:  David Filgueiras-Rama; Jasmina Vasilijevic; Jose Jalife; Sami F Noujaim; Jose M Alfonso; Jose A Nicolas-Avila; Celia Gutierrez; Noelia Zamarreño; Andres Hidalgo; Alejandro Bernabé; Christopher Pablo Cop; Daniela Ponce-Balbuena; Guadalupe Guerrero-Serna; Daniel Calle; Manuel Desco; Jesus Ruiz-Cabello; Amelia Nieto; Ana Falcon
Journal:  Cardiovasc Res       Date:  2021-02-22       Impact factor: 10.787

8.  Myocarditis Associated with Influenza A H1N1pdm2009.

Authors:  Akira Ukimura; Hidetoshi Satomi; Yukimasa Ooi; Yumiko Kanzaki
Journal:  Influenza Res Treat       Date:  2012-12-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.